Consistently, higher plasma level of adiponectin has been related to the decreased risks of CVDs and diabetes mellitus (DM) [11, 12], suggesting the potential role of adiponectin as an important target for the prevention and treatment of CVDs and DM. The gene discussed is ADIPOQ; the disease is diabetes mellitus.